MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
258.45
+3.67
+1.44%
After Hours: 257.50 -0.95 -0.37% 19:59 10/07 EDT
OPEN
256.21
PREV CLOSE
254.78
HIGH
260.68
LOW
255.73
VOLUME
5.41M
TURNOVER
--
52 WEEK HIGH
281.07
52 WEEK LOW
178.91
MARKET CAP
622.84B
P/E (TTM)
29.97
1D
5D
1M
3M
1Y
5Y
1D
3 ‘Strong Buy’ Dividend Aristocrats on Analysts’ Watch List
TipRanks · 7h ago
Spyre: Maintain 'Strong Buy' On Additional SPY072 Shots On Goal Q4 2026 And IBD Combination Potential
Seeking Alpha · 10h ago
Does Long Term Psoriasis Data Change The Bull Case For Johnson & Johnson Stock (JNJ)?
Simply Wall St · 13h ago
Pharma lobby group sues Trump administration over MFN pricing
Seeking Alpha · 13h ago
9 Of 11 Sectors Fall Wednesday As Defensives Lead
Benzinga · 13h ago
Johnson & Johnson Price Target Maintained With a $287.00/Share by Guggenheim
Dow Jones · 15h ago
Guggenheim Reiterates Buy on Johnson & Johnson, Maintains $287 Price Target
Benzinga · 15h ago
Morgan Stanley Releases a Buy Rating on Johnson & Johnson (JNJ)
TipRanks · 16h ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. Its segments include Innovative Medicine and MedTech. The Innovative Medicine segment focuses on various therapeutic areas, oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases and cardiovascular and metabolism. Its products include CARVYKTI (ciltacabtagene autoleucel), DARZALEX (daratumumab), DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), ERLEADA (apalutamide), among others. The MedTech segment develops and manufactures a broad portfolio of products used in cardiovascular, orthopedics, surgery, and vision supporting physicians, hospitals, eye care professionals and healthcare systems across a range of acute and elective procedures. The Cardiovascular portfolio includes electrophysiology products. It is also focused on proprietary Firelink degrader antibody conjugate platform.

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.